Date published: 2025-12-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

Histone cluster 1 H3A Inhibitors

Histone cluster 1 H3A Inhibitors constitute a distinctive category of chemical compounds designed to selectively hinder the activity of histone cluster 1, with a specific emphasis on the H3A subtype. Histones are pivotal proteins in the organization of DNA within the nucleus, forming nucleosomes that provide the structural foundation for chromatin. The H3A designation refers to a variant of histone H3, one of the core histones essential for nucleosome assembly. Histone cluster 1 H3A Inhibitors are intricately designed to interact with specific regions of this histone variant, potentially influencing its binding to DNA and other proteins, thereby modulating chromatin dynamics.

The development of these inhibitors necessitates a profound understanding of the structural characteristics of histone H3A and its specific role within chromatin organization. Engineered for specificity, Histone cluster 1 H3A Inhibitors aim to selectively bind to key regions of H3A, disrupting its normal functions. By employing these inhibitors in experimental contexts, researchers can delve into the consequences of inhibiting this particular histone variant, providing valuable insights into chromatin remodeling and the intricate regulation of gene expression. The study of histones, including variants like H3A, significantly contributes to advancing our understanding of epigenetic mechanisms, offering crucial insights into the dynamic processes governing gene regulation and the complex orchestration of cellular functions at the chromatin level.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Panobinostat

404950-80-7sc-208148
10 mg
$196.00
9
(1)

Panobinostat is a histone deacetylase inhibitor, impacting chromatin structure and potentially influencing the acetylation status of histones, including H3C1.

JIB 04

199596-05-9sc-397040
20 mg
$177.00
(0)

JIB-04 inhibits Jumonji histone demethylases, potentially impacting histone demethylation and the transcriptional regulation of genes, including H3C1.

ACY-1215

1316214-52-4sc-507455
25 mg
$110.00
(0)

Rocilinostat is a histone deacetylase inhibitor, impacting chromatin structure and potentially affecting the acetylation status of histones, including H3C1.

UNC0638

1255580-76-7sc-397012
10 mg
$315.00
(0)

UNC0638 inhibits G9a, a histone methyltransferase, potentially influencing the methylation status of histones and the expression of genes, including H3C1.

GSK-J4

1373423-53-0sc-507551
100 mg
$1275.00
(0)

GSK-J4 inhibits lysine demethylase, potentially influencing histone demethylation and the transcriptional regulation of genes, including H3C1.

EPZ6438

1403254-99-8sc-507456
1 mg
$66.00
(0)

EPZ-6438 targets EZH2, a histone methyltransferase, potentially impacting the methylation of histones and the expression of genes like H3C1.

(S)-2-(4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide

202590-98-5sc-501130
2.5 mg
$330.00
(0)

OTX015 is a bromodomain and extraterminal (BET) protein inhibitor, disrupting interactions between BET proteins and acetylated histones, potentially influencing gene expression.

GSK126

1346574-57-9sc-490133
sc-490133A
sc-490133B
1 mg
5 mg
10 mg
$90.00
$238.00
$300.00
(0)

GSK343 inhibits EZH2, potentially influencing histone methylation patterns and the transcriptional regulation of genes, including H3C1.

C646

328968-36-1sc-364452
sc-364452A
10 mg
50 mg
$260.00
$925.00
5
(1)

C646 is a selective inhibitor of histone acetyltransferase, modulating the acetylation of histones and influencing the expression of associated genes, including H3C1.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

Decitabine is a DNA methyltransferase inhibitor, potentially influencing DNA methylation patterns and the expression of genes, including H3C1.